MiDura-Study (Neuro-Patch in Duraplasty)
- Conditions
- DuraplastyTumor, BrainHydrocephalusDural FistulaVascular MalformationMeningiomaChiari MalformationTethered CordCraniotomySpinal Surgery
- Registration Number
- NCT04189172
- Lead Sponsor
- Aesculap AG
- Brief Summary
The aim of this study is to collect systematically and proactively data regarding the performance of Neuro-Patch, like complications and handling, under daily clinical practice when used as intended by the manufacturer
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 328
- Written informed consent
- Age > 18 years
- Duraplasty using Neuro-Patch® according to the Instructions for Use
- Use in infected regions
- Use in open cerebrocranial traumata
- Use in open spina bifida
- Known hypersensitivity to implant materials
- Pregnancy
- Representation by a legal guardian or under involuntary commitment
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of complications until follow-up (up to one year after surgery) Incidence of complications, with (potential) causal relationship to Neuro-Patch
- Secondary Outcome Measures
Name Time Method Handling measures Intraoperative Evaluation of handling characteristics using a questionnaire containing 5-level Likert scales (excellent, very good, good, fair, poor)
Incidence of complications not related to Neuro Patch until follow-up (up to one year after surgery) Incidence of complications, without causal relationship to Neuro-Patch
Trial Locations
- Locations (4)
Klinik für Neurochirurgie, Universitätsklinikum des Saarlandes
🇩🇪Homburg/Saar, Germany
Hopital Pierre Wertheimer - HCL
🇫🇷Bron, France
Service de Neurochirurgie, Hôpital de la Cavale Blanche
🇫🇷Brest, France
Krankenhaus Ludmillenstift
🇩🇪Meppen, Germany